← Back to Search

Outdoor Exercise Program for Mental Illness (PARCS Trial)

N/A
Waitlist Available
Led By Gina M Besenyi, MPH, PhD
Research Sponsored by Kansas State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after completion of all waves of the study (approximately 2 years)
Awards & highlights
No Placebo-Only Group

Summary

This trialwill test if an outdoor exercise program can help people with mental illness.

Who is the study for?
The PARCS study is for adults with serious mental illness who are part of a community mental health center's peer support program and have been medically cleared to engage in physical activity. It's not suitable for those under 18 or anyone unable to get physician clearance for exercise.
What is being tested?
This study tests a park-based physical activity intervention against an active control group to see if it reduces cardiometabolic risk in adults with serious mental illness participating in peer group treatment.
What are the potential side effects?
While the trial focuses on exercise, potential side effects might include typical risks associated with physical activity such as muscle strains, joint pain, or fatigue, especially if participants are not accustomed to regular exercise.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after completion of all waves of the study (approximately 2 years)
This trial's timeline: 3 weeks for screening, Varies for treatment, and after completion of all waves of the study (approximately 2 years) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability - Change in PA Enjoyment
Acceptability - PA session satisfaction
Feasibility - Attendance
Secondary study objectives
Change in Aerobic Fitness
Change in Exercise Goal Setting
Change in Self-efficacy and Intensions for Spending Time in Nature
+3 more
Other study objectives
Change in Anxiety
Change in Body Composition
Change in Depressive Symptoms
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
PARCS is a park-based physical activity intervention including aerobic and resistance training adapted for adults with serious mental illness and led by certified peer counselors as part of peer group mental health recovery services.
Group II: Active ControlActive Control1 Intervention
The active control group will receive information about the importance of park-based PA and a map of local park locations but will not participate in structured park-based PA sessions. Participants in the control group will be invited to participate in park PA sessions after they have completed posttest. Participants in both groups will receive usual care outpatient peer group treatment services, including routine counseling and health and wellness information/activities given by CPSs.

Find a Location

Who is running the clinical trial?

Augusta UniversityOTHER
215 Previous Clinical Trials
85,590 Total Patients Enrolled
Dartmouth CollegeOTHER
86 Previous Clinical Trials
1,419,638 Total Patients Enrolled
University of CincinnatiOTHER
439 Previous Clinical Trials
638,648 Total Patients Enrolled
Kansas State UniversityLead Sponsor
36 Previous Clinical Trials
13,147 Total Patients Enrolled
Gina M Besenyi, MPH, PhDPrincipal InvestigatorKansas State University

Media Library

Park-based physical activity Clinical Trial Eligibility Overview. Trial Name: NCT05457179 — N/A
Severe mental illness Research Study Groups: Intervention, Active Control
Severe mental illness Clinical Trial 2023: Park-based physical activity Highlights & Side Effects. Trial Name: NCT05457179 — N/A
Park-based physical activity 2023 Treatment Timeline for Medical Study. Trial Name: NCT05457179 — N/A
~10 spots leftby Mar 2025